Optimark and Thrombocytopenia aggravated - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia aggravated is reported as a side effect among people who take Optimark (gadoversetamide), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Omniscan, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Thrombocytopenia aggravated when taking Optimark. It is created by eHealthMe based on reports of 3,054 people who have side effects when taking Optimark from the FDA, and is updated regularly.

What is Optimark?

Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.

What is Thrombocytopenia aggravated?

Thrombocytopenia aggravated (decrease of platelets in blood) is found to be associated with 2,377 drugs and 874 conditions by eHealthMe. Check the latest studies of Thrombocytopenia aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

3,054 people reported to have side effects when taking Optimark.
Among them, 14 people (0.46%) have Thrombocytopenia aggravated.

Could Optimark cause Thrombocytopenia aggravated?

Among these 14 people:

How long have people been on Optimark when they have Thrombocytopenia aggravated? *

What is the gender of people who have Thrombocytopenia aggravated when taking Optimark? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Thrombocytopenia aggravated when taking Optimark? *

What are other drugs people take besides Optimark? *

Omniscan: 8 people, 57.14%
Magnevist: 6 people, 42.86%
Norvasc: 5 people, 35.71%
Nitroglycerin: 4 people, 28.57%
Flexeril: 4 people, 28.57%
Zofran: 4 people, 28.57%
Lipitor: 3 people, 21.43%
Lanoxin: 3 people, 21.43%
Codeine Sulfate: 3 people, 21.43%
Levalbuterol Hydrochloride: 2 people, 14.29%

What are other side effects people have besides Thrombocytopenia aggravated? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 13 people, 92.86%
Oedema Peripheral (superficial swelling): 11 people, 78.57%
Cardiac Failure Congestive: 8 people, 57.14%
Pain: 7 people, 50.00%
Splenomegaly (enlargement of spleen): 7 people, 50.00%
Vision Blurred: 6 people, 42.86%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 42.86%
Chest Pain: 6 people, 42.86%
Renal Cyst (kidney cyst): 6 people, 42.86%
Abdominal Pain: 5 people, 35.71%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 9 people, 64.29%
Renal Mass (mass in kidney): 3 people, 21.43%
Renal Abscess (pus in kidney): 3 people, 21.43%
Submandibular Mass: 2 people, 14.29%
Neck Mass (mass in neck): 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Chest Pain: 2 people, 14.29%
Ventricular Dysfunction (heart dysfunction): 1 person, 7.14%
Nuclear Magnetic Resonance Imaging Abdominal: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Optimark and have Thrombocytopenia aggravated?

- Check whether Thrombocytopenia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Optimark:

Optimark (3,055 reports)

Browse all side effects of Optimark:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia aggravated:

Thrombocytopenia aggravated (2,377 drugs)

Browse all the conditions that are associated with Thrombocytopenia aggravated:

Thrombocytopenia aggravated (874 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadoversetamide (the active ingredients of Optimark) and Optimark (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.